measuregroup/AID1802156

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID319495672_AID1802156_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID319495672_AID1802156_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID319495665_AID1802156_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID319495665_AID1802156_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID319495665_AID1802156_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID319495672_AID1802156_PMID_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08684 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10635 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11712
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Inhibition Assay from US Patent US9242943: \"1,4 oxazines as BACE1 and/or BACE2 inhibitors\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID319495672 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID319495665
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1802156

Total number of triples: 15.